WCG ClinSphere™ Total Feasibility Releases Self-Serve Capabilities that Optimize Clinical Trial Site Selection

CARY, N.C., March 27, 2025 /PRNewswire/ — WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG ClinSphere™ Total Feasibility’s Software-as-a-Service (SaaS) technology solution, designed to address the most important clinical trial study start-up decisions for sponsors and contract research organizations (CROs). This innovative application streamlines communication and enables faster decision-making by providing centralized data access with standardized questions that allows sites to pre-populate questionnaires to reduce redundancy and enhance clinical trial success.

WCG ClinSphere™ Total Feasibility doubles site feasibility response rates compared to the industry average and significantly reduces timelines and burdens for both sponsors and sites during the site evaluation and selection process. Users now have an option of self-service or high-touch experience with wrap-around services, providing clinical development insights and site identification for end-to-end study start-up support.

“On average, sites spend 200 hours per month completing feasibility activities, and up to 87% of questionnaires are considered redundant,” said Cristin MacDonald, vice president, Client Delivery, WCG. “Our solution automates and streamlines these processes, allowing research teams to focus on new and critical information, ultimately enhancing study success and accelerating timelines.”

“WCG ClinSphere™ Total Feasibility revolutionizes the study start-up process,” said Sam Srivastava, chief executive officer, WCG. “By integrating comprehensive data combined with user-friendly tools, we empower research teams with the insights they need to make informed decisions quickly. This innovation is central to our mission to improve lives by accelerating research, bringing life-saving treatments to patients sooner.”

Key features of WCG ClinSphere™ Total Feasibility include:

Enhanced Investigator and Site Profiles: Utilizing the power of WCG’s extensive data, surveys are pre-populated to reduce site workload and accelerate responses. With more than 300 standardized fields, users can access comprehensive details on site capabilities, staff, and logistics.

Data-Driven Decision Support: Leveraging information from proprietary, robust data, the application offers unique insights, streamlining the assessment process to find the best-fit investigators and sites for each study.

Interactive Dashboards and Real-Time Tracking: Sponsors have immediate access to progress and status updates through interactive dashboards. Real-time tracking, scoring, and response analysis enable rapid decision-making.

Integrated Feasibility Solutions: WCG’s Total Feasibility solution minimizes redundancy, speeds results, and improves collaboration, reducing the workload for sites and providing faster turnaround times.

For sponsors and CROs, the new self-service capability offers a valuable tool to streamline operations, reduce costs, and improve relationships with sites during the feasibility process for their clinical trials. This launch represents a significant advancement in WCG’s comprehensive suite of solutions designed to support the entire clinical trial lifecycle.

For more information on WCG ClinSphere™ Total Feasibility, visit https://www.wcgclinical.com/technologies/total-feasibility/

About WCG

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical.

View original content to download multimedia:https://www.prnewswire.com/news-releases/wcg-clinsphere-total-feasibility-releases-self-serve-capabilities-that-optimize-clinical-trial-site-selection-302413173.html

SOURCE WCG

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago